Abstract
In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety and posttraumatic stress disorder (PTSD). Since the termination of a period of research from the 1950s to the
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have